New2Trip: Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients w/ Aortic Stenosis https://t.co/gxkISwDD9i
New2Trip: Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients w/ Aortic Stenosis https://t.co/PzvY7SjRt1
New2Trip: Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients w/ Aortic Stenosis https://t.co/PzvY7SjRt1
New2Trip: Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients w/ Aortic Stenosis https://t.co/PzvY7SjRt1
New2Trip: Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients w/ Aortic Stenosis https://t.co/PzvY7SjRt1
RT @PPibarot: TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aort…
RT @PPibarot: TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aort…
RT @PPibarot: TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aort…
RT @JACCJournals: Could this mean the end of #SAVR for #vhdAS treatment? Study led by Dr. @SuzanneJBaron reports #TAVR is associated with m…
RT @JACCJournals: Could this mean the end of #SAVR for #vhdAS treatment? Study led by Dr. @SuzanneJBaron reports #TAVR is associated with m…
RT @PPibarot: TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aort…
RT @JACCJournals: Could this mean the end of #SAVR for #vhdAS treatment? Study led by Dr. @SuzanneJBaron reports #TAVR is associated with m…
RT @JACCJournals: Could this mean the end of #SAVR for #vhdAS treatment? Study led by Dr. @SuzanneJBaron reports #TAVR is associated with m…
RT @JACCJournals: Could this mean the end of #SAVR for #vhdAS treatment? Study led by Dr. @SuzanneJBaron reports #TAVR is associated with m…
This is truly a provocative title. In regards to keeping an unbiased posture, I guess @JACCJournals has definitely gone off tracks.
RT @JACCJournals: Could this mean the end of #SAVR for #vhdAS treatment? Study led by Dr. @SuzanneJBaron reports #TAVR is associated with m…
RT @JACCJournals: Could this mean the end of #SAVR for #vhdAS treatment? Study led by Dr. @SuzanneJBaron reports #TAVR is associated with m…
RT @JACCJournals: Could this mean the end of #SAVR for #vhdAS treatment? Study led by Dr. @SuzanneJBaron reports #TAVR is associated with m…
RT @JACCJournals: Could this mean the end of #SAVR for #vhdAS treatment? Study led by Dr. @SuzanneJBaron reports #TAVR is associated with m…
RT @JACCJournals: Could this mean the end of #SAVR for #vhdAS treatment? Study led by Dr. @SuzanneJBaron reports #TAVR is associated with m…
Could this mean the end of #SAVR for #vhdAS treatment? Study led by Dr. @SuzanneJBaron reports #TAVR is associated with more meaningful early and late health status benefits compared to SAVR. https://t.co/KtH4f8iL2V #JACC https://t.co/zaR1iGzTN9
RT @djc795: Important work by @SuzanneJBaron and the team at @MidAmericaHeart. First randomized trial to demonstrate not only improved sh…
RT @djc795: Important work by @SuzanneJBaron and the team at @MidAmericaHeart. First randomized trial to demonstrate not only improved sh…
Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis https://t.co/O0rGVjIqJ4
RT @VictorDayan1: @JACCJournals publishes in their main journal, data from health status in PARTNER 3 which already was published in @JW…
RT @PPibarot: TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aort…
RT @PPibarot: TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aort…
RT @djc795: Important work by @SuzanneJBaron and the team at @MidAmericaHeart. First randomized trial to demonstrate not only improved sh…
RT @PPibarot: TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aort…
RT @djc795: Important work by @SuzanneJBaron and the team at @MidAmericaHeart. First randomized trial to demonstrate not only improved sh…
RT @djc795: Important work by @SuzanneJBaron and the team at @MidAmericaHeart. First randomized trial to demonstrate not only improved sh…
RT @PPibarot: TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aort…
RT @djc795: Important work by @SuzanneJBaron and the team at @MidAmericaHeart. First randomized trial to demonstrate not only improved sh…
RT @djc795: Important work by @SuzanneJBaron and the team at @MidAmericaHeart. First randomized trial to demonstrate not only improved sh…
RT @PPibarot: TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aort…
RT @VictorDayan1: @JACCJournals publishes in their main journal, data from health status in PARTNER 3 which already was published in @JW…
RT @djc795: Important work by @SuzanneJBaron and the team at @MidAmericaHeart. First randomized trial to demonstrate not only improved sh…
Yes. At 12 months. That's only 1 year follow-up.
Important work by @SuzanneJBaron and the team at @MidAmericaHeart. First randomized trial to demonstrate not only improved short term quality of life with TAVR, but benefit through 1 year as well. Benefit seems to be accentuated in more symptomatic pati
RT @VictorDayan1: @JACCJournals publishes in their main journal, data from health status in PARTNER 3 which already was published in @JW…
RT @VictorDayan1: @JACCJournals publishes in their main journal, data from health status in PARTNER 3 which already was published in @JW…
@JACCJournals publishes in their main journal, data from health status in PARTNER 3 which already was published in @JWatch. How should we interpret this decision ? https://t.co/RpUMQwo9rz
RT @PPibarot: TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aort…
RT @PPibarot: TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aort…
RT @PPibarot: TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aort…
TAVR associated with better improvement in QoL vs. SAVR in PARTNER 3. Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis | JACC: Journal of the American College of Cardiology https://t.co/O
RT @SmithBIDMC: Thank you to @SuzanneJBaron for a fantastic recap and discussion yesterday @SmithBIDMC on the #COAPT cost-effectiveness ana…
RT @SmithBIDMC: Thank you to @SuzanneJBaron for a fantastic recap and discussion yesterday @SmithBIDMC on the #COAPT cost-effectiveness ana…
RT @SmithBIDMC: Thank you to @SuzanneJBaron for a fantastic recap and discussion yesterday @SmithBIDMC on the #COAPT cost-effectiveness ana…
RT @SmithBIDMC: Thank you to @SuzanneJBaron for a fantastic recap and discussion yesterday @SmithBIDMC on the #COAPT cost-effectiveness ana…
Thank you to @SuzanneJBaron for a fantastic recap and discussion yesterday @SmithBIDMC on the #COAPT cost-effectiveness analysis & #PARTNER3 health status outcomes which she presented last month at #TCT2019: https://t.co/HSPbhzCg7b & https://t.co/S
RT @JACCJournals: Watch Dr. @SuzanneJBaron and #JACCINT Editor Dr. David Moliterno discuss #TCT2019 LBCT in low-risk patients who underwent…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
RT @vass_vassiliou: More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from…
More on #valves! Health status following #TAVR better than #SAVR immediately and up to 12 months for low risk pts from PARTNER3 @jacc https://t.co/pvT8Tl0Q2V #epeeps #cardioed #epeeps #EchoFirst #WhyCMR @mmamas1973 @AnastasiaSMihai @ShrillaB @mirvatalasna
@FernandoBiguria @igeorge1975 And as just presented by my colleague, @SuzanneJBaron at TCT last week, QOL still favored TAVR at 1 year as well. https://t.co/LkBCIROFU9
RT @VictorDayan1: Once again @JACCJournals allows false statements to be published. Is p=0.07 significant ? An upper regulatory body is r…
RT @JACCJournals: Watch Dr. @SuzanneJBaron and #JACCINT Editor Dr. David Moliterno discuss #TCT2019 LBCT in low-risk patients who underwent…
RT @JACCJournals: Watch Dr. @SuzanneJBaron and #JACCINT Editor Dr. David Moliterno discuss #TCT2019 LBCT in low-risk patients who underwent…
RT @JACCJournals: Watch Dr. @SuzanneJBaron and #JACCINT Editor Dr. David Moliterno discuss #TCT2019 LBCT in low-risk patients who underwent…
RT @JACCJournals: Watch Dr. @SuzanneJBaron and #JACCINT Editor Dr. David Moliterno discuss #TCT2019 LBCT in low-risk patients who underwent…
RT @VictorDayan1: Once again @JACCJournals allows false statements to be published. Is p=0.07 significant ? An upper regulatory body is r…
RT @JACCJournals: Watch Dr. @SuzanneJBaron and #JACCINT Editor Dr. David Moliterno discuss #TCT2019 LBCT in low-risk patients who underwent…
RT @JACCJournals: Watch Dr. @SuzanneJBaron and #JACCINT Editor Dr. David Moliterno discuss #TCT2019 LBCT in low-risk patients who underwent…
Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis https://t.co/M8i6M9hkkl
RT @JACCJournals: Watch Dr. @SuzanneJBaron and #JACCINT Editor Dr. David Moliterno discuss #TCT2019 LBCT in low-risk patients who underwent…
RT @JACCJournals: Watch Dr. @SuzanneJBaron and #JACCINT Editor Dr. David Moliterno discuss #TCT2019 LBCT in low-risk patients who underwent…
RT @JACCJournals: Watch Dr. @SuzanneJBaron and #JACCINT Editor Dr. David Moliterno discuss #TCT2019 LBCT in low-risk patients who underwent…
RT @JACCJournals: Watch Dr. @SuzanneJBaron and #JACCINT Editor Dr. David Moliterno discuss #TCT2019 LBCT in low-risk patients who underwent…
Watch Dr. @SuzanneJBaron and #JACCINT Editor Dr. David Moliterno discuss #TCT2019 LBCT in low-risk patients who underwent TAVR had a better quality of life compared with surgery from PARTNER 3. Read full paper and the editorial in #JACC: https://t.co/rdYrQ
RT @VictorDayan1: Once again @JACCJournals allows false statements to be published. Is p=0.07 significant ? An upper regulatory body is r…
RT @VictorDayan1: Once again @JACCJournals allows false statements to be published. Is p=0.07 significant ? An upper regulatory body is r…
Once again @JACCJournals allows false statements to be published. Is p=0.07 significant ? An upper regulatory body is required to oversee this. @ACCinTouch https://t.co/pa73sDBKww